{
  "id": "62211b973a8413c65300006c",
  "type": "yesno",
  "question": "Are G-quadruplexes(G4) possible drug targets for glioblastoma?",
  "ideal_answer": "The  2H2-6M(4)-oxazole telomestatin derivative (6OTD) targets Glioma stem cells through G4 stabilization and promotion of DNA damage responses. Therefore, G4s are promising therapeutic targets for glioblastoma.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33213893",
    "http://www.ncbi.nlm.nih.gov/pubmed/26845351",
    "http://www.ncbi.nlm.nih.gov/pubmed/28620243",
    "http://www.ncbi.nlm.nih.gov/pubmed/34459951",
    "http://www.ncbi.nlm.nih.gov/pubmed/26908447",
    "http://www.ncbi.nlm.nih.gov/pubmed/24030712"
  ],
  "snippets": [
    {
      "text": "These observations indicate that 6OTD targets GSCs through G4 stabilization and promotion of DNA damage responses. Therefore, G4s are promising therapeutic targets for glioblastoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28620243",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28620243",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "G-quadruplex (G4) DNA is a type of quadruple helix structure formed by a continuous guanine-rich DNA sequence. Emerging evidence in recent years authenticated that G4 DNA structures exist both in cell-free and cellular systems, and function in different diseases, especially in various cancers, aging, neurological diseases, and have been considered novel promising targets for drug design.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34459951",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, G4s are promising therapeutic targets for glioblastoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28620243",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Guanine-rich oligonucleotides (GROs) are promising therapeutic candidate for cancer treatment and other biomedical application.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24030712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These findings are valuable to the design and rationale behind the possible targeted drug delivery to specific cellular organelles using GROs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24030712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The G-quadruplex (G4) DNA, which has been developed as a potential anticancer target in drug screening and design, plays a crucial role in the oncogene transcription and translation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33213893",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, a novel G4-directed therapeutic strategy could specifically target cancer stem cells in GBM.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26845351",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}